New software tool for analyzing kinases; Dotmatics software to support Cancer Therapeutics CRC;

> R&D software provider Dotmatics says that Cancer Therapeutics CRC has deployed the company's enterprise platform for research at multiple locations. Item

> Formedix has spotlighted the company's latest Transform for Publication products for clinical trials data. Release

> A group from the University of Saskatchewan has developed software to analyze kinases, which, when mutated, are culprits in a number of cancers. Announcement

> An informatics expert from the Ohio State University plans to upgrade a web-based tool for analyzing large datasets to help researchers explore the spread of infectious diseases. Report

> Biovest International ($BVTI) has tapped Dr. Eduardo Sotomayor of the H. Lee Moffitt Cancer Center & Research Institute in Tampa for its scientific advisory board. Release



Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.